GO:0030301 cholesterol transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030301 cholesterol transport is the directed movement of cholesterol into, out of, or within a cell, or between cells, by means of a transporter or pore.
• Cholesterol transport is essential for dietary cholesterol uptake, cellular membrane homeostasis, and reverse cholesterol transport from peripheral tissues to the liver.
• Key proteins include NPC1L1, ABCA1, ABCG1, SR-BI, LDLR, and Aster/GRAMD1 proteins, which mediate sterol movement across membranes and between organelles.
• Defects in cholesterol transport contribute to atherosclerosis, cardiovascular disease, and metabolic disorders.
• Cholesterol transport is regulated by miRNAs and natural compounds, offering therapeutic targets.
• CRISPR-based knockout, knock-in, and overexpression models are powerful tools to dissect cholesterol transport mechanisms and identify causal genes.
Description
Cholesterol transport (GO:0030301) is a fundamental biological process defined as the directed movement of cholesterol, cholest-5-en-3-beta-ol, into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. This process is critical for maintaining cellular cholesterol homeostasis, enabling dietary cholesterol absorption, and facilitating reverse cholesterol transport, which removes excess cholesterol from peripheral tissues to the liver for excretion. Dysregulation of cholesterol transport is implicated in a wide range of diseases, including atherosclerosis, cardiovascular disease, and metabolic syndrome. Understanding the molecular players and regulatory mechanisms of cholesterol transport is therefore of paramount importance for both basic research and therapeutic development. Recent studies have identified numerous proteins and regulatory pathways that orchestrate cholesterol movement, such as NPC1L1, ABCA1, and Aster proteins. This article provides a comprehensive overview of the definition, mechanisms, key genes, and research methodologies associated with GO:0030301, with a focus on how CRISPR-based models can accelerate discoveries in this field.
cholesterol transport At A Glance
| GO ID | GO:0030301 |
|---|---|
| GO term | cholesterol transport |
| Ontology | biological_process |
| Synonym | None |
| Major function | Directed movement of cholesterol into, out of, or within a cell, or between cells, via transporter or pore |
| Related processes | Reverse cholesterol transport, dietary cholesterol uptake, intracellular cholesterol trafficking |
| Key transporters | NPC1L1, ABCA1, ABCG1, SR-BI, LDLR, Aster/GRAMD1 |
| Disease relevance | Atherosclerosis, cardiovascular disease, metabolic disorders |
| Research methods | CRISPR knockout/knock-in, overexpression, imaging, biochemical assays |
What Is GO:0030301?
According to the Gene Ontology, cholesterol transport (GO:0030301) is the directed movement of cholesterol, cholest-5-en-3-beta-ol, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. This process encompasses the movement of cholesterol across membranes, between organelles, and between cells, and is essential for lipid homeostasis and cellular function.
Why Is cholesterol transport Important in Cell Biology?
Cholesterol transport is vital for maintaining cellular cholesterol balance and overall metabolic health. It governs the absorption of dietary cholesterol in the intestine, the delivery of cholesterol to peripheral tissues, and the removal of excess cholesterol via reverse cholesterol transport. Disruptions in these processes lead to cholesterol accumulation in arteries, contributing to atherosclerosis and cardiovascular disease. Moreover, cholesterol transport influences membrane fluidity, signal transduction, and lipid raft formation, impacting numerous physiological and pathological pathways. Therefore, studying cholesterol transport is essential for understanding lipid metabolism and developing therapies for related diseases.
• Maintains cellular cholesterol homeostasis and membrane integrity.
• Mediates intestinal absorption of dietary cholesterol via NPC1L1.
• Enables reverse cholesterol transport, protecting against atherosclerosis.
• Involves lysosome-peroxisome membrane contacts for intracellular cholesterol trafficking.
• Regulated by miRNAs and natural compounds, offering therapeutic targets.
• Dysregulation linked to cardiovascular disease, metabolic syndrome, and neurodegeneration.
• Aster proteins facilitate nonvesicular cholesterol transport from the plasma membrane to the ER.
• Bile acids promote intracellular cholesterol transport and NPC1L1 recycling.
• Cholesterol transport is critical for steroid hormone synthesis and bile acid production.
• CRISPR screens can identify novel regulators of cholesterol transport.
What Happens During cholesterol transport?
Dietary Cholesterol Uptake
In simple terms: The body takes in cholesterol from food through the intestine.
Dietary cholesterol is absorbed in the small intestine via the transporter NPC1L1, which mediates the uptake of cholesterol from the intestinal lumen into enterocytes. This process is essential for delivering cholesterol to the body and is a target for drugs like ezetimibe. Aster proteins also facilitate nonvesicular transport of cholesterol from the plasma membrane to the endoplasmic reticulum, contributing to dietary cholesterol uptake.
Intracellular Cholesterol Trafficking
In simple terms: Inside cells, cholesterol moves between different compartments.
Cholesterol is transported between organelles such as lysosomes and peroxisomes through membrane contact sites, as demonstrated by Chu et al.. This transport is crucial for cholesterol distribution and metabolism. Additionally, bile acids mediate intracellular cholesterol transport, promoting NPC1L1 recycling and intestinal cholesterol absorption.
Reverse Cholesterol Transport
In simple terms: Excess cholesterol is removed from tissues and sent to the liver.
Reverse cholesterol transport (RCT) is the process by which excess cholesterol from peripheral tissues is transported to the liver for excretion. This involves cholesterol efflux from macrophages via ABCA1 and ABCG1, uptake by HDL, and delivery to the liver via SR-BI. Steck et al. propose that active cholesterol regulates RCT, ensuring efficient removal of excess cholesterol.
Regulation of Cholesterol Transport
In simple terms: The process is controlled by various molecules to meet cellular needs.
Cholesterol transport is regulated by miRNAs and natural compounds, which can modulate the expression of transporters and enzymes. For example, specific miRNAs target genes involved in RCT, influencing cholesterol efflux and uptake. Natural molecules such as phytochemicals can also regulate cholesterol transport, offering potential therapeutic strategies.
Key Genes Involved in GO:0030301 cholesterol transport
The following genes and proteins play major roles in cholesterol transport, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NPC1L1 | Mediates intestinal cholesterol absorption | Target for ezetimibe; knockout models reduce cholesterol uptake |
| ABC1 | Mediates cholesterol efflux to apoA-I | Defects cause Tangier disease; overexpression increases HDL |
| ABCG1 | Mediates cholesterol efflux to HDL | Knockout increases atherosclerosis in mice |
| SR-BI | Mediates selective uptake of HDL cholesterol in liver | Knockout alters HDL levels and atherosclerosis |
| LDLR | Mediates uptake of LDL cholesterol | Mutations cause familial hypercholesterolemia |
| Aster/GRAMD1 | Facilitates nonvesicular cholesterol transport | Knockout impairs dietary cholesterol uptake |
| NPC1 | Mediates lysosomal cholesterol export | Mutations cause Niemann-Pick type C disease |
| NPC2 | Transfers cholesterol within lysosome | Mutations cause Niemann-Pick type C disease |
| ABCA1 | Cholesterol efflux to apoA-I | Target for HDL-raising therapies |
| CYP7A1 | Converts cholesterol to bile acids | Regulates cholesterol catabolism |
| CYP27A1 | Converts cholesterol to bile acids | Mutations cause cerebrotendinous xanthomatosis |
| SREBP2 | Regulates cholesterol synthesis and uptake | Feedback control of cholesterol homeostasis |
| HMGCR | Rate-limiting enzyme in cholesterol synthesis | Target of statins |
| LCAT | Esterifies cholesterol on HDL | Deficiency causes fish-eye disease |
| CETP | Transfers cholesteryl esters between lipoproteins | Target for HDL-raising drugs |
| PLTP | Transfers phospholipids and cholesterol between lipoproteins | Knockout affects HDL metabolism |
| PCSK9 | Promotes LDLR degradation | Target for cholesterol-lowering antibodies |
| miRNAs (e.g., miR-33) | Regulate cholesterol transport genes | Therapeutic targets for modulating RCT |
How Is cholesterol transport Regulated?
Cholesterol transport is regulated at multiple levels, including transcriptional control by SREBP2 and LXR, post-translational modifications, and non-coding RNAs such as miRNAs. For instance, miR-33 targets ABCA1 and ABCG1, reducing cholesterol efflux. Natural compounds can also modulate cholesterol transport by affecting the expression or activity of transporters and enzymes. Additionally, bile acids regulate intracellular cholesterol transport and NPC1L1 recycling, linking bile acid signaling to cholesterol absorption.
cholesterol transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ABCA1 | Tangier disease, atherosclerosis | Knockout mice, overexpression cell lines |
| NPC1 | Niemann-Pick type C disease | Patient-derived fibroblasts, NPC1 knockout cells |
| LDLR | Familial hypercholesterolemia | LDLR knockout mice, knock-in of patient mutations |
| SR-BI | Altered HDL metabolism, atherosclerosis | SR-BI knockout mice |
| NPC1L1 | Cholesterol absorption disorders | NPC1L1 knockout mice, overexpression in enterocytes |
Atherosclerosis and Cardiovascular Disease
Impaired reverse cholesterol transport leads to cholesterol accumulation in macrophages and arterial walls, promoting atherosclerosis. Defects in ABCA1, ABCG1, or SR-BI impair cholesterol efflux, increasing cardiovascular risk. Therapies targeting cholesterol transport, such as HDL-raising agents, are under investigation.
Niemann-Pick Type C Disease
Mutations in NPC1 or NPC2 cause Niemann-Pick type C disease, characterized by lysosomal cholesterol accumulation. Chu et al. demonstrated that lysosome-peroxisome membrane contacts are disrupted in NPC1 deficiency, contributing to cholesterol trafficking defects.
Metabolic Disorders
Dysregulation of cholesterol transport is linked to metabolic syndrome, diabetes, and fatty liver disease. Natural compounds that modulate cholesterol transport may offer therapeutic benefits.
From cholesterol transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate cholesterol efflux? | Knockout of gene X in macrophages, measure efflux to apoA-I |
| Does mutation Y affect NPC1L1 function? | Point mutation knock-in in intestinal cells, measure cholesterol uptake |
| Can overexpression of ABCA1 increase HDL? | Overexpression of ABCA1 in hepatocytes or mice |
| Where is protein Z localized during cholesterol transport? | Tagged knock-in of Z with fluorescent protein, imaging |
| What is the role of Aster proteins in dietary cholesterol uptake? | Aster knockout mice, measure cholesterol absorption |
| How do miRNAs regulate cholesterol transport? | miRNA knockout or overexpression, target gene expression |
How to Study the cholesterol transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cholesterol efflux assay | Movement of cholesterol from cells to acceptors | Assess ABCA1/ABCG1 function |
| Intestinal cholesterol absorption assay | Uptake of dietary cholesterol | Evaluate NPC1L1 inhibitors |
| Live-cell imaging | Intracellular cholesterol trafficking | Study lysosome-peroxisome contacts |
| CRISPR knockout screen | Genes affecting cholesterol transport | Identify novel regulators |
| RNA-seq | Transcriptional changes | miRNA target identification |
| Proteomics | Protein expression and interactions | Discover cholesterol transport complexes |
| Lipidomics | Cholesterol and lipid species quantification | Measure cholesterol distribution |
| Flow cytometry | Cholesterol content in cells | Quantify efflux in macrophages |
Biochemical Assays for Cholesterol Transport
Cholesterol efflux assays using radiolabeled cholesterol or fluorescent analogs measure the movement of cholesterol from cells to acceptors like apoA-I or HDL. Intestinal cholesterol absorption can be assessed using dual-isotope methods in mice.
Imaging of Cholesterol Trafficking
Fluorescent cholesterol analogs (e.g., BODIPY-cholesterol) and GFP-tagged proteins enable live-cell imaging of cholesterol transport between organelles and membranes. High-resolution microscopy reveals membrane contact sites involved in cholesterol transfer.
CRISPR Screens for Cholesterol Transport Regulators
Genome-wide CRISPR knockout screens can identify genes essential for cholesterol uptake or efflux. For example, a screen for regulators of NPC1L1 trafficking could uncover new therapeutic targets.
Transcriptomics and Proteomics
RNA-seq and proteomics can profile changes in gene expression and protein abundance upon modulation of cholesterol transport, revealing regulatory networks.
How CRISPR Can Be Used to Study GO:0030301 cholesterol transport
Knockout
CRISPR knockout of genes like ABCA1, NPC1L1, or Aster proteins in cell lines or mice can elucidate their roles in cholesterol transport. For example, NPC1L1 knockout reduces intestinal cholesterol absorption.
Point Mutation
Introducing disease-associated point mutations (e.g., in NPC1 or LDLR) via CRISPR base editing or HDR allows study of functional consequences on cholesterol transport.
Knock-in
Knock-in of tagged versions of cholesterol transporters (e.g., GFP-NPC1L1) enables real-time tracking of protein localization and dynamics.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression of genes like ABCA1 can increase cholesterol efflux and raise HDL levels, providing therapeutic insights.
How EDITGENE Supports cholesterol transport Research
Researchers studying cholesterol transport-related genes often need to determine whether a candidate gene is causally involved in cholesterol movement, and CRISPR-based models provide a robust way to test this. By systematically knocking out, mutating, or overexpressing genes, scientists can dissect the molecular machinery of cholesterol transport and validate therapeutic targets.
Contact EDITGENE today to design your custom CRISPR model for cholesterol transport research.
Frequently Asked Questions About cholesterol transport
What is cholesterol transport GO:0030301?
Cholesterol transport (GO:0030301) is the directed movement of cholesterol into, out of, or within a cell, or between cells, by means of a transporter or pore.
What genes are involved in cholesterol transport?
Key genes include NPC1L1, ABCA1, ABCG1, SR-BI, LDLR, and Aster/GRAMD1 proteins.
How is cholesterol transported in the body?
Cholesterol is transported via lipoproteins, transporters like NPC1L1 and ABCA1, and nonvesicular mechanisms involving Aster proteins.
What is reverse cholesterol transport?
Reverse cholesterol transport is the process by which excess cholesterol from peripheral tissues is transported to the liver for excretion, involving ABCA1, ABCG1, and SR-BI.
What diseases are linked to defective cholesterol transport?
Defective cholesterol transport is linked to atherosclerosis, cardiovascular disease, Niemann-Pick type C disease, and metabolic disorders.
How do miRNAs regulate cholesterol transport?
miRNAs such as miR-33 target genes involved in cholesterol efflux, thereby regulating reverse cholesterol transport.
What is the role of NPC1L1 in cholesterol transport?
NPC1L1 mediates intestinal cholesterol absorption and is the target of ezetimibe.
How can CRISPR be used to study cholesterol transport?
CRISPR knockout, knock-in, and overexpression models allow functional dissection of genes involved in cholesterol transport.
What are Aster proteins?
Aster proteins (GRAMD1) facilitate nonvesicular cholesterol transport from the plasma membrane to the endoplasmic reticulum.
How is cholesterol transport regulated?
Cholesterol transport is regulated by transcription factors like SREBP2, miRNAs, bile acids, and natural compounds.
Conclusion
Cholesterol transport (GO:0030301) is a central biological process that maintains cellular cholesterol homeostasis and systemic lipid balance. Its dysregulation underlies major diseases such as atherosclerosis and Niemann-Pick type C disease. Advances in CRISPR-based models and high-throughput screening are accelerating the discovery of new players and therapeutic targets in cholesterol transport. EDITGENE offers comprehensive services to support these research efforts.
References
- 1. Chu BB et al.. 2015. Cholesterol transport through lysosome-peroxisome membrane contacts.. Cell 161(2):291-306 PMID: 25860611
- 2. Ferrari A et al.. 2023. Aster-dependent nonvesicular transport facilitates dietary cholesterol uptake.. Science 382(6671):eadf0966 PMID: 37943936
- 3. Steck TL et al.. 2023. Is reverse cholesterol transport regulated by active cholesterol?. J Lipid Res 64(6):100385 PMID: 37169287
- 4. Lian Z et al.. 2019. Reverse cholesterol transport-related miRNAs and their regulation by natural functional compounds.. Curr Protein Pept Sci 20(10):1004-1011 PMID: 31453783
- 5. Xiao J et al.. 2023. Bile acids-mediated intracellular cholesterol transport promotes intestinal cholesterol absorption and NPC1L1 recycling.. Nat Commun 14(1):6469 PMID: 37833289
- 6. Tan M et al.. 2021. Recent developments in the regulation of cholesterol transport by natural molecules.. Phytother Res 35(10):5623-5633 PMID: 34327759
- 7. Betters JL et al.. 2010. NPC1L1 and cholesterol transport.. FEBS Lett 584(13):2740-7 PMID: 20307540
- 8. Ohashi R et al.. 2005. Reverse cholesterol transport and cholesterol efflux in atherosclerosis.. QJM 98(12):845-56 PMID: 16258026
